5 June, 2024

Pablo Herrero: “We work long term with companies and we believe that we can provide them with ideas from physiotherapy that they can transfer to the market”

In this interview, the researcher from IIS Aragon and the University of Zaragoza talks about his work leading the 'iHealthy' Group (GIIS105) and the challenges they face.
5 June, 2024

Researcher Carlos Martín receives the Aragonese Prize of the Year

The professor leads the Mycobacteria Genetics team at the University of Zaragoza and the Aragon Health Research Institute (IIS Aragón), which develops the Aragonese vaccine against tuberculosis.
4 June, 2024

The potential of the tuberculosis vaccine against cancer

Researcher Nacho Aguiló from the University of Zaragoza, the Networked Biomedical Research Center for Respiratory Diseases (Ciberes) and the Aragón Health Research Institute (IIS Aragón), is working to demonstrate, together with his team, that these live vaccines are capable of reverse the effects of asthma and lung and bladder tumors.
3 June, 2024

A new therapeutic approach would reduce mortality from COVID-19

An international study led by Julián Pardo, a researcher at the University of Zaragoza and the IIS Aragón, opens the way to more effective therapies, by reducing inflammation and preventing respiratory failure.